Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

NCT01003600 | Completed

• 1 other identifier: 09-133
• Study Type: observational
• Target: 177
• Locations: 1 country
• Sites: 2

Brief Summary

We are doing this study to learn more about colon and rectal cancer survivors. We want to know if survivors want more information about life after cancer. Do cancer survivors want to know more about their own cancer? Do cancer survivors want to know about their treatment? Do cancer survivors want to know what health care they should get in the future? We want to know what information to give to cancer survivors when they finish treatment.

Conditions

Colon Cancer; Rectal Cancer

Keywords

Survivorship; Quality of Life; Questionnaire; 09-133

Outcome Measures

Primary Outcomes (1)

• Assess colorectal cancer survivors' basic knowledge of their own cancer history, including date of diagnosis, stage, and treatments received.

  6 months to 2 years after completion of treatment

Secondary Outcomes (4)

• Assess survivors' knowledge of medical issues relevant to colorectal cancer survivors.

  6 months to 2 years after completion of treatment

• Describe the types of health care providers that survivors have visited since completing treatment for colorectal cancer.

  6 months to 2 years after completion of treatment

• Assess survivors' preferences for the content, format, and delivery of survivorship care plans.

  6 months to 2 years after completion of treatment

• Assess whether survivors who had concerns about working after cancer treatment spoke with health care professionals about their concerns.

  6 months to 2 years after completion of treatment

Study Arms (1)

Questionnaire

This study is a cross-sectional survey study to be administered to adults who completed treatment for nonmetastatic colorectal cancer at MSKCC or at Queens Cancer Center (QCC) at Queens Hospital between 6 months and 2 years ago and have no evidence of disease at the time of study enrollment.

Behavioral: Questionnaire

Interventions

Questionnaire BEHAVIORAL

The questionnaire will be administered by telephone and will take approximately 20-30 minutes. The questionnaire will elicit survivor responses along five domains: knowledge about diagnosis and treatment, knowledge about ongoing risks and recommended testing, history of health care utilization since the end of treatment, preferences for relevant information about these topics, and employment after the end of cancer treatment.

Also known as: The questionnaire will be administered using a Computer Assisted Telephone Interview (CATI), system. The CATI form of the questionnaire enables the interviewer to read aloud from a script and, enter responses into the computer in real-time, regardless of whether the interview is conducted on the, phone or in person. The CATI form of the questionnaire enables the interviewer to read aloud from a, script and enter responses into the computer in real-time, regardless of whether the interview is, conducted on the phone or in person.

Questionnaire

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults who completed treatment for nonmetastatic colorectal cancer at MSKCC or at Queens Cancer Center (QCC) at Queens Hospital

You may qualify if:

• years of age or older at diagnosis
• Diagnosed with first primary colorectal cancer (stage I-III)
• Completed last treatment for colorectal cancer (surgery, chemotherapy, or radiation) at least 6 months and no more than 2 years before the date of study enrollment
• Able to speak English, because questionnaire is only available in English
• Able to provide informed consent
• Received all treatment for colorectal cancer at MSKCC or QCC or, surgical treatment at an outside facility, and all other treatment (chemotherapy or radiation) at MSKCC or QCC

You may not qualify if:

• Undergoing active treatment for colorectal cancer
• Diagnosed with metastatic colorectal cancer
• Prior history of colorectal or any other cancer (except non-melanoma skin cancer)
• Diagnosed with new or recurrent colorectal or other cancer after the primary colorectal cancer diagnosis
• Received a survivorship care plan from the treating institution

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead
• Queens Cancer Center of Queens Hospital: collaborator

Study Sites (2)

Queens Cancer Center of Queens Hospital

Jamaica, New York, 11432, United States

Location

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Memorial Sloan-Kettering Cancer Center

MeSH Terms

Conditions

Colonic Neoplasms; Rectal Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Colorectal Neoplasms; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Talya Salz, PhD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 28, 2009
• First Posted: October 29, 2009
• Study Start: October 1, 2009
• Primary Completion: November 1, 2014
• Study Completion: November 1, 2014
• Last Updated: December 2, 2014

Record last verified: 2014-11

Locations

US (2)